Corporate Office
10 N. Martingale Rd., Suite #400Schaumburg, Illinois 60173, U.S.A.
Life Sciences | Validated AI at Scale
AI Governance for Life Sciences Innovation and Assurance
Life sciences AI can accelerate discovery, trials, safety monitoring, medical affairs, quality, manufacturing, and commercial operations. It also expands regulatory, privacy, quality, patient-safety, and evidentiary obligations. Acer Innovation helps life sciences leaders build an AI operating model that supports both innovation velocity and defensible assurance.
Explore AI Governance North StarGxP-aware AI lifecycleClinical evidence traceabilitySafety and quality controlsRegulator-ready governance
AI Governance for Life Sciences Innovation and Assurance
Home / Industries / Life Sciences
Executive mandate
Life sciences AI must be innovation-grade and inspection-ready
The enterprise needs to prove what AI is doing, what data it used, how it was validated, who approved it, how it is monitored, and what controls activate when outputs become unreliable. Governance must be embedded in discovery, clinical operations, regulatory affairs, safety, quality, medical affairs, and commercial workflows.
- Classify AI by patient impact, regulated process dependency, data sensitivity, autonomy, and evidence requirements.
- Create AI passports for material systems with lineage, validation, risk tier, monitoring, approval trail, and retirement criteria.
- Connect AI Governance to privacy, security, quality, regulatory, vendor, clinical, and data governance functions.
- Use risk-tiered gates so low-risk productivity improves speed while high-impact systems receive enhanced assurance.
Life sciences control stack
Where governance creates defensible velocity
1
Drug discovery and research AI
Control data provenance, scientific validity, reproducibility, IP exposure, model limitations, and human expert review.
2
Clinical trial operations
Govern recruitment, protocol design support, site selection, adherence analytics, patient communications, and participant fairness.
3
Safety and pharmacovigilance
Monitor signal detection, case processing, adverse-event workflows, triage automation, auditability, and escalation paths.
4
Regulatory and medical content
Manage AI-assisted submissions, labeling support, medical writing, claims review, source traceability, and final human accountability.
5
Quality and manufacturing
Apply controls for predictive maintenance, anomaly detection, batch review, root-cause support, and production decision influence.
6
Commercial and medical affairs
Govern segmentation, personalization, field enablement, customer engagement, content generation, and compliant disclosure workflows.
Acer Innovation North Star
AI Governance operating-model principles embedded across this page
1
Governance as an operating system
Treat AI Governance as enterprise infrastructure with decision rights, controls, evidence, monitoring, escalation, auditability, and measurable accountability.
2
Enterprise AI system of record
Maintain a living inventory for models, agents, copilots, embedded AI, vendor tools, data sources, owners, geographies, risk tiers, and retirement plans.
3
Risk-tiered intake and classification
Route every use case through a formal gateway based on purpose, affected stakeholders, decision impact, data sensitivity, autonomy, and regulatory exposure.
4
Human-in-command decision rights
Define decision tiers for AI-recommended, AI-assisted, AI-executed with override, AI-executed with prior approval, and prohibited AI autonomy.
5
AI passport and evidence package
Require purpose, owner, lineage, vendor dependency, testing evidence, approval history, monitoring metrics, known limits, restrictions, and incident pathway before production.
6
Lifecycle gates and continuous monitoring
Govern ideation, data readiness, model selection, validation, deployment, drift, change management, incident response, and retirement as one auditable lifecycle.
7
Agentic AI permission boundaries
Put hard limits around tools, data access, transactions, external communications, code deployment, privileged actions, kill switches, and real-time monitoring.
8
Data, privacy, security, and lineage
Connect AI Governance to data classification, access controls, retention, provenance, privacy reviews, cybersecurity testing, prompt and output logging, and leakage detection.
9
Third-party AI assurance
Procurement becomes a control point with vendor attestations, model purpose, training-data posture, audit rights, subcontractors, incident notice, and contractual safeguards.
10
Incident response and near-miss learning
Treat hallucinations, bias events, privacy leakage, cyber compromise, drift, unsafe automation, and control failures as reportable operating signals.
11
Board-visible value and risk dashboards
Report AI adoption, value realization, risk tiering, control maturity, incidents, drift, override rates, customer impact, regulatory exposure, and remediation velocity.
12
Global control backbone
Map a common enterprise baseline to NIST AI RMF, ISO/IEC 42001, ISO/IEC 23894, EU AI Act expectations, privacy law, cyber standards, and sector-specific regulation.
Board questions
Life sciences AI requires traceability from hypothesis to evidence
| Executive control | Board-level question | Acer Innovation deliverable |
|---|---|---|
| Data provenance | Can we prove where the data came from and whether it was permitted for this AI use? | Data lineage map, classification, consent/permitted-use review, access and retention controls. |
| Validation evidence | Can we demonstrate appropriate accuracy, robustness, bias, explainability, and monitoring? | Validation protocol, independent challenge, model card, test evidence, monitoring threshold design. |
| Regulated workflow impact | Which regulated or safety-critical processes are influenced by AI outputs? | Process map, risk tier, owner assignment, approval gates, quality and regulatory control overlay. |
| Human accountability | Who remains accountable when AI informs clinical, regulatory, quality, or commercial decisions? | Decision-rights matrix, sign-off rules, escalation model, exception workflow. |
First 90 Days
Board-ready deliverables for immediate traction
1
AI Governance charter
Board committee oversight, executive sponsor, AI Governance Board, escalation rights, risk appetite, and prohibited-use thresholds.
2
AI inventory and risk tiering
Mandatory intake, system of record, risk classification, owner assignment, approval status, control status, and kill-switch owner.
3
Regulatory and control mapping
Obligation register mapped to NIST AI RMF, ISO/IEC 42001, privacy, cyber, model risk, procurement, sector rules, and internal controls.
4
Production gates and evidence packs
Risk assessment, data lineage, model card, validation results, privacy review, security test, fairness review, vendor evidence, and approval trail.
5
Monitoring and incident playbook
Drift, bias, prompt, RAG source quality, abuse, privacy leakage, security events, remediation aging, and near-miss reporting.
6
Executive dashboard
Board view connecting AI value realization, adoption, residual risk, third-party concentration, incidents, exceptions, and remediation velocity.